Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
107Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $33.33M | $1.28M | $0.02 |
| 2024 | $19.49M | $670.5K | $0.01 |
| 2023 | $19.15M | $2.48M | $0.05 |
| 2022 | $5.77M | $79.7K | $0.00 |
Social Signal Score
Earnings
Mon, Nov 9(in 3 months)
Consensus estimate $-0.02 per share
Typical surprise +0.0% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Aug 13$-0.04 vs $-0.03miss
- Wed, May 13$-0.03 vs $-0.04beat
- Wed, Mar 25$-0.01 vs $-0.01beat
- Mon, Nov 10$0.01 vs $0.01beat
- Mon, Jul 21$0.01 vs $0.01beat
- Mon, Apr 14$0.01 vs $0.02miss
Estimates and results for HIT via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
Project earnings forward and see what return today's price implies.
Seeded from HIT's reported EPS growth of 137.1% a year over 3 years. Historical EPS growth of 137% reflects a recovery from a low base and won't persist. Capped at 30% as a starting point.
- EPS in 5 years
- $0.09
- Implied price
- $1.53
- Return from $1.00
- 8.8% a year
To earn 15.0% a year on these assumptions you'd need to buy at $0.76 — -24.3% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 12 | 15 | 18 | 21 | 24 |
|---|---|---|---|---|---|
| 20.0% | -7.4% | -3.2% | 0.4% | 3.6% | 6.4% |
| 25.0% | -3.6% | 0.8% | 4.6% | 7.9% | 10.8% |
| 30.0% | 0.3% | 4.9% | 8.8% | 12.2% | 15.2% |
| 35.0% | 4.2% | 8.9% | 13.0% | 16.5% | 19.6% |
| 40.0% | 8.0% | 12.9% | 17.1% | 20.8% | 24.1% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Mentions (3)
- Newsseekingalpha.com·1d ago·Positive
Health In Tech, Inc. (HIT) Q2 2026 Earnings Call Transcript Health In Tech, Inc. (HIT) Q2 2026 Earnings Call Transcript
View source ↗ - Newsmarketbeat.com·1d ago·Neutral
Health In Tech Q2 Earnings Call Highlights Health In Tech NASDAQ: HIT reported second-quarter revenue of $8.1 million, down 13.5% from $9.3 million in the year-earlier period, as the company said the onboarding of a new carrier shifted certain policy effective dates into later quarters.
View source ↗ - Newsprnewswire.com·1d ago·Neutral
Health In Tech Reports Second Quarter 2026 Financial Results Contracted Revenue of $32.3 Million as of June 30, 2026 Pipeline Revenue of $66.3 Million as of July 31, 2026 Distribution Partners Grew 19.9% Year Over Year STUART, Fla., Aug. 13, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or the "Company"), an AI-enabled InsurTech platform company, today announced its unaudited financial results for the three and six months ended June 30, 2026.
View source ↗